9月,Corvus制药公司短期利息增加了31.1%。 Corvus Pharmaceuticals experienced a 31.1% increase in short interest in September.

Corvus Pharmaceuticals， Inc.（纳斯达克股票代码：CRVS）9月份的空头股数增长了31.1%，总计2,150,000股。 Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) saw a 31.1% rise in short interest in September, totaling 2,150,000 shares. 该公司报告的每股净损失为0.07美元,比预期的好。 The company reported a net loss of $0.07 per share, better than expected. 公司市值为4.2034亿美元, 股票价格比率为-12.92. It holds a market cap of $420.34 million and a PE ratio of -12.92. 分析师有好坏参半的评级,其中一人将其降级为“销售”,其他人则提高价格目标,平均为10.83美元。 Analysts have mixed ratings, with one downgrading it to "sell" while others raised price targets, averaging $10.83. 机构投资者拥有公司的46.64%。 Institutional investors own 46.64% of the company.